[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352409-105":59,"doc-detail-352409-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","impact-of-postoperative-radiotherapy-on-combined-local-scc-events-and-survival-in-non-metastatic-oral-and-pharyngeal-squamous-cell-carcinoma","Impact of postoperative radiotherapy on combined local SCC events and survival in non-metastatic oral and pharyngeal squamous cell carcinoma","","Background: Whether postoperative radiotherapy (PORT) reduces post-treatment malignant events in oral and pharyngeal squamous cell carcinoma (SCC) remains uncertain, especially in population-based settings where true recurrence cannot be separated from second primary tumors (SPTs). Methods: Using SEER data (1975–2021), a retrospective cohort of 26,953 surgically treated patients evaluated PORT versus non-PORT for combined local SCC events and overall survival (OS). Competing-risk Fine–Gray, Poisson trend, and Kaplan–Meier with 1:1 propensity score matching were used. Results showed fewer combined local events with PORT but no adjusted OS benefit. Conclusions: PORT improves registry-captured local disease control across subsites, without an observed survival advantage after adjustment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/impact-of-postoperative-radiotherapy-on-combined-local-scc-events-and-survival-in-non-metastatic-oral-and-pharyngeal-squamous-cell-carcinoma/352409/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/impact-of-postoperative-radiotherapy-on-combined-local-scc-events-and-survival-in-non-metastatic-oral-and-pharyngeal-squamous-cell-carcinoma/352409.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical question does the study address?","Question",{"text":112,"@type":113},"It evaluates whether postoperative radiotherapy reduces malignant post-treatment events in non-metastatic oral and pharyngeal SCC, and how that relates to overall survival.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was postoperative radiotherapy (PORT) defined and what data source was used?",{"text":117,"@type":113},"PORT was defined as postoperative external-beam radiotherapy, and the analysis used SEER data from 1975 to 2021.",{"name":119,"@type":110,"acceptedAnswer":120},"Did PORT improve overall survival after adjustment?",{"text":121,"@type":113},"After propensity score matching, overall survival did not differ significantly between PORT and non-PORT groups.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352409,1790842158,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Chen et al. Discover Oncology (2026) 17:302 [https://doi.org/10.1007/s12672-026-04449-8](https://doi.org/10.1007/s12672-026-04449-8)  \nDiscover Oncology  \nANALYSIS Open Access  \nImpact of postoperative radiotherapy on combined local SCC events and survival in non-metastatic oral and pharyngeal squamous cell carcinoma  \nYiquan Chen1, Ruihuan Gao1, Jingjing Wei3, Xueying Liu1, Yixuan Liang4, Zhiyi Wu2 and Hai-jun Wu 1,5*  \n*Correspondence: Hai-jun Wu [wuhaijun@csu.edu.cn](wuhaijun@csu.edu.cn)  \n1Xiangya Hospital, Central South University, Changsha 410008, China 2School of Pharmacy, Jishou University, Jishou 416000, China 3The Second Xiangya Hospital of Central South University, Changsha 410011, China 4School of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, China  \n5Medical College, Central South University, Changsha, China  \nAbstract  \nBackground Whether postoperative radiotherapy (PORT) reduces post-treatment malignant events in oral and pharyngeal squamous cell carcinoma (SCC) remains uncertain, particularly in population-based settings where true recurrence cannot be distinguished from second primary tumors (SPTs) . Using SEER data (1975–2021), we evaluated the association between PORT and combined local SCC events—subsequent SCCs of identical morphology occurring within C00–C14—and assessed its impact on overall survival (OS) .  \nMethods A retrospective cohort of 26,953 patients with first primary non-metastatic oral/pharyngeal SCC who underwent surgery was identified. PORT was defined as postoperative external-beam radiotherapy. The primary endpoint was combined local SCC events, reflecting SEER-captured recurrence-or SPT-like occurrences. Fine– Gray competing-risk models estimated subdistribution hazard ratios (sHRs), treating non-cancer death as the competing event. Poisson regression evaluated calendaryear trends. OS was assessed using Kaplan–Meier analysis with 1:1 propensity score matching (PSM) to adjust for baseline imbalances. Sensitivity analyses restricted to classical oral cavity SCC (C00–C06) and excluded all pharyngeal subsites.  \nResults Among 26,953 patients, 8,355 (31 . 0%) received PORT. PORT recipients had more adverse disease characteristics, including higher rates of regional-stage disease and high-grade morphology. During follow-up, 146 patients (0 . 54%) developed combined local SCC events, with lower incidence in the PORT group (0 . 7% vs. 0. 2%, P \u003C 0. 001) . PORT independently reduced the risk of combined events (sHR 0 . 34, 95% CI 0.20–0. 59) . Results were consistent across all subgroups and sensitivity analyses. After PSM, OS did not differ significantly between PORT and non-PORT groups (HR 0 . 97, 95% CI 0 .89–1. 12) . Among patients who developed combined SCC events, OS likewise remained comparable.  \nConclusions In this large, population-based study, PORT was associated with a substantially lower risk of registry-captured local SCC events across oral and pharyngeal subsites, although no adjusted survival advantage was observed. These findings  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](h","cbCaidqgW9FaHZoP","https://ap.wps.com/l/cbCaidqgW9FaHZoP","pdf",1572098,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n# Keywords","[{\"question\":\"What clinical question does the study address?\",\"answer\":\"It evaluates whether postoperative radiotherapy reduces malignant post-treatment events in non-metastatic oral and pharyngeal SCC, and how that relates to overall survival.\"},{\"question\":\"How was postoperative radiotherapy (PORT) defined and what data source was used?\",\"answer\":\"PORT was defined as postoperative external-beam radiotherapy, and the analysis used SEER data from 1975 to 2021.\"},{\"question\":\"Did PORT improve overall survival after adjustment?\",\"answer\":\"After propensity score matching, overall survival did not differ significantly between PORT and non-PORT groups.\"}]","Impact of postoperative radiotherapy on combined local SCC events and survival in non-metastatic oral and pharyngeal squamous cell carcinoma | PDF",1790099404,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e339bb9345433b957216abce7289cf35.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6454d41a57d7c8643b2c40a9c8ecd34.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2100cf7e450ae418dbb01c7de9e9309b.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09c0bd923e370f61fb72be7ff3692dac.webp",980,1306]